{"data":{"id":"us/21-cfr-520.2340","jurisdiction":"us","citation":"21 CFR 520.2340","heading":"Tepoxalin.","body":"(a) Specifications. Each tablet contains 30, 50, 100, or 200 milligrams (mg) tepoxalin.\n(b) Sponsor. See No. 000061 in § 510.600(c) of this chapter.\n(c) Conditions of use in dogs—(1) Amount. 10 mg per kilogram (/kg) daily; or 20 mg/kg on the initial day of treatment, followed by 10 mg/kg daily.\n(2) Indications for use. For the control of pain and inflammation associated with osteoarthritis.\n(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER E—ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS","PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"222d297d874ba9f47af611223984810328f5aa69b07da1dd7c7de89548afddfe","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-520.2335","next":"us/21-cfr-520.2345"},"notice":"GroundRules: Original legal text. Not legal advice."}